1. Home
  2. MBIO vs AMSS Comparison

MBIO vs AMSS Comparison

Compare MBIO & AMSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.39

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

HOLD

Current Price

$0.36

Market Cap

4.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
AMSS
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.2M
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
MBIO
AMSS
Price
$0.39
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.8K
★ 144.3K
Earning Date
11-06-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 98.99
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.71
Revenue Next Year
$405.45
$20.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.32
52 Week High
$1.69
$2.44

Technical Indicators

Market Signals
Indicator
MBIO
AMSS
Relative Strength Index (RSI) 30.11 26.11
Support Level N/A N/A
Resistance Level $0.56 $0.81
Average True Range (ATR) 0.03 0.06
MACD -0.01 0.00
Stochastic Oscillator 14.81 6.75

Price Performance

Historical Comparison
MBIO
AMSS

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

Share on Social Networks: